8 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #regimens #medications ... #pharmacology #IDSA
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... For most indications ... #management #algorithm ... pharmacology #treatment #medications ... decisionaid #cardiology #hematology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Prophylaxis): Indications ... Indication for Discontinuing ... AviumComplex #MAC #IDSA ... Prevention #Treatment #management
Gout - Diagnosis and Management Summary

3 Conditions for Gout to Manifest:
1. Hyperuricemia
2. Monosodium urate deposition in
Diagnosis and Management ... Metabolic syndrome • Medications ... comorbidities/drug ... dosage in CKD • Indications ... gout • Oral drug
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Noncardiac: • Pulmonary ... disease • Drugs ... Cardioversion • Ablation therapy ... Absolute warfarin indications ... AFib #diagnosis #management
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... ., concomitant medications ... intraocular levels of drug ... Cytomegalovirus #CMV #IDSA ... Prevention #Treatment #management
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... prevent TB disease) Indications ... result Preferred Therapy ... (Duration of Therapy ... Prevention #Treatment #management
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... cardiovascular or pulmonary ... in MDS-related indications ... for MDS-related indications ... #algorithm #hematology